{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:49:36Z","timestamp":1769878176189,"version":"3.49.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Rebamipide ophthalmic suspension was launched in Japan in 2012 and is used for the treatment of dry eye.<\/jats:p><jats:p><jats:bold>Case Presentation:<\/jats:bold> We report two cases of orbital abscess, which resulted from dacryocystitis that occurred after administration of rebamipide ophthalmic suspension. Computed tomography images showed an eyeball deformity in one case and exophthalmos in the other. In both cases, light microscopy, scanning electron microscopy and energy dispersive X-ray examinations revealed lacrimal sac concretions, which contained calcium phosphate crystals that were surrounded by microorganisms. Lacrimal sac concretion removal from the lacrimal sacs during dacryocystorhinostomies was performed on both patients. Although the postoperative outcome was favorable in one case, vision was lost in the other case due to the development of retinal artery occlusion as a complication of the orbital abscess, despite lacrimal sac concretion removal and administration of antimicrobials.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> This is the first case report to highlight that rebamipide ophthalmic suspension can cause an orbital abscess via development of lacrimal sac concretion. Ophthalmologists should be aware that rebamipide ophthalmic suspension might induce the formation of concretion in the lacrimal sac.<\/jats:p>","DOI":"10.3389\/fmed.2021.646397","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T08:18:07Z","timestamp":1628583487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: A Rare Orbital Abscess Caused by Dacryocystitis After Administration of Rebamipide Ophthalmic Suspension"],"prefix":"10.3389","volume":"8","author":[{"given":"Hitoshi","family":"Imamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuo","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumika","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/01.ico.0000126436.25751.fb","article-title":"Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model","volume":"23","author":"Urashima","year":"2004","journal-title":"Cornea."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e98390","DOI":"10.1371\/journal.pone.0098390","article-title":"Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sj\u00f6gren syndrome","volume":"9","author":"Arakaki","year":"2014","journal-title":"PLoS ONE."},{"key":"B3","first-page":"1741","article-title":"Retrospective review of dacryostenosis, dacryocystitis and foreign body in eye or lacrimal duct under administration of rebamipide ophthalmic suspension (Mucosta\u00ae Ophthalmic Suspension UD 2%)","volume":"32","author":"Sugimoto","year":"2015"},{"key":"B4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0002-9394(14)73709-2","article-title":"An eyelash nidus for dacryoliths of the lacrimal excretory and secretory systems","volume":"11","author":"Baratz","year":"1991","journal-title":"Am J Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00417-018-3996-7","article-title":"Electron microscopic features of the lacrimal sac mucopeptide concretions","volume":"256","author":"Ali","year":"2018","journal-title":"Graefes Arch Clin Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12348-019-0182-y","article-title":"Interleukin\u22126 inhibition in the management of non\u2013infections uveitis and beyond","volume":"9","author":"Karkhur","year":"2019","journal-title":"J Ophthalmic Inflamm Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","article-title":"Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non\u2013Sj\u00f6gren syndrome dry eye patients","volume":"156","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol."},{"key":"B8","first-page":"447","article-title":"Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent","volume":"295","author":"Sun","year":"2000","journal-title":"J Pharmacol Exp Ther."},{"key":"B9","article-title":"Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action?","author":"Tarnawski","year":"1998","journal-title":"Dig Dis Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0891-5849(94)00110-6","article-title":"Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study","volume":"18","author":"Naito","year":"1995","journal-title":"Free Radic Biol Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1006\/bbrc.1995.1378","article-title":"Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages","volume":"208","author":"Arias-Negrete","year":"1995","journal-title":"Biochem Biophys Res Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1365-2567.1998.00646.x","article-title":"Specific NF-\u03baB blockade selectively inhibits tumour necrosis factor-\u03b1-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells","volume":"95","author":"Jobin","year":"1998","journal-title":"Immunology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.18632\/oncotarget.2783","article-title":"Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation","volume":"6","author":"Hsu","year":"2015","journal-title":"Oncotarget."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/SCS.0000000000006237","article-title":"Surgical treatment of a dacryocystitis by using venous catheter","volume":"31","author":"Meduri","year":"2020","journal-title":"J Craniofac Surg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e229376","DOI":"10.1136\/bcr-2019-229376","article-title":"Endoscopic treatment of a periorbital fat herniation caused by spontaneous solution of continuity of the papyracea lamina","volume":"12","author":"Galletti","year":"2019","journal-title":"BMJ Case Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.646397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T08:18:10Z","timestamp":1628583490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.646397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":15,"alternative-id":["10.3389\/fmed.2021.646397"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.646397","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"article-number":"646397"}}